Manufacturing activity surges in New York region to highest level in nearly three years

Date:

Share post:




The New York Federal Reserve’s Empire State business conditions index, a gauge of manufacturing activity in the state, surged 43.1 points in November to 31.2, the regional Fed bank said Friday. It is the highest level in nearly three years.



Source link

Alexandra Williams
Alexandra Williams
Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Recent posts

Related articles

RFK Jr. is not a fan of weight-loss drugs or vaccines. Stocks are tanking.

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs...

RFK Jr. would rattle health markets as head of HHS, but his confirmation is far from certain, analyst says

Robert F. Kennedy Jr. would create “significantly more volatility” in health markets if he is confirmed as...

Vaccine-maker stocks like Moderna, Pfizer drop as Trump picks RFK Jr. to lead HHS

Shares of vaccine makers lost ground Thursday, hit by news that President-elect Donald Trump was naming vaccine...

Powell says Fed doesn’t need to hurry to cut interest rates

Federal Reserve Chair Jerome Powell said Thursday that the economy is in a good place, with inflation...

Biogen’s stock rises after E.U. regulator reverses negative view of Alzheimer’s drug

Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease...

Off-price retailers could thrive, BofA says, citing this bullish data point

BofA analysts reiterated buy ratings on Burlington Stores Inc., Ross Stores Inc. and TJX Cos. Thursday, ahead...

Republicans clinch control of House, setting stage for quicker action on extending tax cuts

Republicans are poised to keep their hold on the House in the new year, as the AP...

This biotech’s stock could double if its treatment for major depressive disorder succeeds, says Mizuho

Mizuho reiterated its bullish stance on biotech Neumora Therapeutics Inc. on Wednesday, and predicted a positive outcome...